Charles River Laboratories International Inc.

CRL | NYSE

$279.01

+$0.95 (+0.34%)

At close: Sep 21, 2026, 4:00 PM ET

$279.01

$0 (0.00%)

After-hours: Sep 21, 2026, 5:55 PM ET

Fiscal Year Period Ending	FY 2025 Dec 26, 2025	FY 2024 Dec 27, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	4.02B	4.05B	4.13B	3.98B	3.54B	2.92B
Cost of Revenue	2.79B	2.72B	2.63B	2.51B	2.21B	1.85B
Gross Profit	1.23B	1.33B	1.5B	1.46B	1.33B	1.07B
Operating Income	507.84M	227.35M	617.26M	650.98M	589.86M	432.73M
Interest Income	4.94M	8.58M	5.2M	780K	652K	834K
Pretax Income	-99.5M	93.11M	581.28M	622.99M	480.71M	447.11M
Net Income	-144.34M	10.3M	474.62M	486.23M	390.98M	364.3M
Selling & General & Admin	743.07M	751M	747.86M	665.1M	619.92M	528.94M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	-25.34M	353.47M	137.44M	146.58M	124.86M	111.88M
Operating Expenses	717.73M	1.1B	885.3M	811.68M	744.78M	640.81M
Interest Expense	107.03M	126.29M	136.71M	59.29M	73.91M	86.43M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	3.51B	3.82B	3.51B	3.33B	2.95B	2.49B
Income Tax Expense	42.66M	67.82M	100.91M	130.38M	81.87M	81.81M
Shares Outstanding (Basic)	49.56M	51.38M	51.23M	50.81M	50.29M	49.55M
Shares Outstanding (Diluted)	49.56M	51.63M	51.45M	51.3M	51.43M	50.61M
EPS (Basic)	-2.91	0.20	9.27	9.57	7.77	7.35
EPS (Diluted)	-2.91	0.20	9.22	9.48	7.60	7.20
EBITDA	410.84M	581.14M	1.03B	986.15M	820.16M	768.47M
EBIT	7.53M	219.4M	717.99M	682.28M	554.62M	533.55M
Depreciation & Amortization	403.31M	361.74M	314.12M	303.87M	265.54M	234.92M